PubRank

Jeffrey Crippin

Author PubWeight™ 11.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003 1.06
2 Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. J Infect Dis 2002 1.03
3 Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation 2007 0.97
4 Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med 2016 0.97
5 Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 2003 0.93
6 Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg 2005 0.82
7 Modulation of immune responses following solid organ transplantation by microRNA. Exp Mol Pathol 2012 0.82
8 Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol 2003 0.81
9 Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation. J Clin Gastroenterol 2012 0.78
10 A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Liver Transpl 2008 0.78
11 Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus. AIDS Patient Care STDS 2003 0.78
12 Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis. Transplantation 2007 0.76
13 Elevation of serum riboflavin carrier protein in hepatocellular carcinoma. Hepatol Res 2006 0.76
14 Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients. HPB (Oxford) 2013 0.75